• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Oncology Announces September 2020 Conference Schedule

August 26, 2020 By Celyad Oncology

Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in September 2020:

Wells Fargo 2020 Virtual Healthcare Conference

Date: Wednesday, September 9, 2020
Time: 9:20 a.m. EDT
Webcast: A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website

Knowledge for Growth 2020

Date:September 9 – September 10, 2020

H.C. Wainwright 22nd Annual Global Investment Conference

Date: Monday, September 14, 2020
Time: 3:30 p.m. EDT
Webcast: A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website
Download press release(s)
Communiqué de presse
Press Release
Persbericht

Filed Under: Uncategorized

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use